Journal article
Motexafin gadolinium (MGd) overcomes adverse survival effect of anemia in brain metastases (BM) patients treated with whole brain radiation therapy (WBRT): analysis of a phase III randomized trial
Authors
Kumar P; Mehta MP; Rodrigus P; Suh J; Sagar S; Kunkler I; Carrie C; Smith JA; Phan S; Renschler MF
Journal
International Journal of Radiation Oncology • Biology • Physics, Vol. 57, No. 2,
Publisher
Elsevier
Publication Date
October 1, 2003
DOI
10.1016/s0360-3016(03)00838-1
ISSN
0360-3016